Início › Câncer de Ovário › Virgínia Ocidental
Ensaios clínicos de Câncer de Ovário em Virgínia Ocidental
10 estudos para Câncer de Ovário estão buscando participantes em locais em Virgínia Ocidental.
Cidades em Virgínia Ocidental
Texto oficial do estudo (Inglês)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Vandalia Health/CAMC Institute for Academic Medicine, Charleston
- Edwards Comprehensive Cancer Center, Huntington
- West Virginia University Healthcare, Morgantown
RecrutandoFase 2
Todas as idades · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05564377A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- West Virginia University School of Medicine /ID# 274556, Morgantown
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT06890338A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- West Virginia University Hospitals /ID# 278965, Morgantown
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 22 de set. de 2026 · NCT07059845A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- West Virginia University, Morgantown
RecrutandoFase 2
Idades de 18 a 99 · Mulheres · Atualizado em 15 de set. de 2026 · NCT07023627Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- West Virginia University, Morgantown
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 15 de set. de 2026 · NCT07214779A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- United Hospital Center, Bridgeport
- West Virginia University Charleston Division, Charleston
- WVUH-Berkely Medical Center, Martinsburg
- e mais 4
Recrutando
Idades de 35 a 50 · Mulheres · Atualizado em 7 de ago. de 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- United Hospital Center, Bridgeport
- WVUH-Berkely Medical Center, Martinsburg
- West Virginia University Healthcare, Morgantown
- e mais 3
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06580314A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- West Virginia University Health Sciences Campus, Morgantown
RecrutandoFase 2
Idades 8 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT05503797Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
- CAMC Institute for Academic Medicine - Cancer Research Center, Charleston
- WVU Cancer Institute, Morgantown
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 14 de jul. de 2026 · NCT05804370SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Morgantown
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.